Platinum PainCare Announces IPO Filing Following Dual Recognition at 'Future Healthcare 100' Within Six Months of Establishment

On May 6, 2023, the “2023 Top 100 Future Healthcare Companies” list was released. As an outstanding enterprise in the digital healthcare sector, BOTONG HEALTH was honored with the “Pengcheng Award · Enterprise of the Year with Potential” and the Value Sector Award.

BOTONG HEALTH is China’s first pain management platform to focus on “cancer pain” as its entry point. Driven by intelligent technology, grounded in data interaction, and powered by advanced algorithms, it empowers healthcare institutions to deliver end-to-end pain management solutions.

BOTONG HEALTH, Established Less Than a Year Ago"Built a product matrix integrating hardware and software.", pioneering a holistic pain management solution empowered by digital health,Core products have covered more than 100 medical institutions across China, and its data engine has accumulated over 50,000 cases of data.. BOTONG HEALTH continues to deepen its expertise in the field of cancer pain management, establishing a leading management platform in the pain sector within China.

At the Digital Therapeutics Industry Innovation and Practice Forum held on the afternoon of May 5,Professor Wang Jiejun, Founder of BOTONG HEALTHIt is noted that, thanks to the efforts of all sectors of society over the past decade, the overall five-year survival rate for malignant tumors in China has increased from 30.9% to 40.5%. With the improvement in overall cancer survival rates, cancer prevention and control have gradually entered an era of chronic disease management. While continuously advancing treatment standards, increasing attention is being paid to the quality of life of cancer patients. Among various concerns, “cancer pain,” as one of the most common symptoms experienced by cancer patients, significantly impacts their quality of life.

Professor Wang Jiejun Delivers Keynote Address and Participates in Roundtable Discussion at the Conference

The “Blue Book on China’s Pain Prevention and Control and Health Promotion Strategy: Report on the Development of Pain Medicine in China (2020)” points out that “China has over 300 million patients with chronic pain, a number that is growing rapidly by 10 to 20 million each year, with total treatment costs amounting to approximately RMB 500 billion.” Behind these figures lies the immense burden borne by pain patients and their families, as well as society at large.

In the face of severe challenges, policy initiatives have clearly mandated the promotion and implementation of the ICD-11 disease classification system in China, which includes diagnoses such as “chronic pain” and “chronic cancer pain.” This development creates new opportunities for patient admission, medical quality control, and health insurance reimbursement. Meanwhile, BOTONG HEALTH is leveraging its industry expertise to build a leading pain management platform, aiming to enhance healthcare professionals’ awareness of the importance of pain management during oncology treatment, while providing them with actionable standards and practical technological tools.

BTS (The 6D Pain Assessment System) is one of BOTONG HEALTH’s core products. It not only integrates multiple clinical tests but also incorporates proprietary algorithms to form a systematic, multidimensional “Total Pain” comprehensive assessment. Compared with the traditional Brief Pain Inventory (BPI), the BTS assessment requires less completion time, is more user-friendly, and is preferred by patients. In predicting breakthrough pain and neuropathic pain, the BTS achieves accuracy rates exceeding 90%. It is reported thatBOTONG HEALTH expects to launch the BTS Intelligent Pain Assessment Robot in 2023. Large-scale clinical study data on BTS are forthcoming, and an article on pain crises is also set to be published, making these developments highly anticipated.

Ms. Ye Lei, Partner at BOTONG HEALTHFormer Executive Secretary of the Regional Medical Collaboration Consortium of the Wu Jieping Medical Foundation; successfully listed on the 2022 “Sci-Tech Innovation China” Youth Entrepreneurship List—Yangtze River Delta G60 Sci-Tech Innovation Corridor U30; Research Fellow at the China Association for Optimization of Capital Construction; with many years of in-depth experience in the healthcare market sector.

She stated that BOTONG HEALTH has successfully achieved commercialization in its B2B services. Meanwhile, the company has made successful explorations in its medical service business model by implementing cancer pain quality control through the CPDP Medical Consortium. By deploying its products, systems, and equipment into healthcare institutions, and pursuing both vertical deepening and horizontal expansion, BOTONG HEALTH aims to extend its products and services to more hospitals and benefit more patients. The pilot construction of PICU is scheduled to launch in Q3 2023.

Ms. Ye Lei, Partner at BOTONG HEALTH

Working on the front lines, Ms. Ye Lei has a clear perception of the changes in the digital healthcare industry. She shared that oncology diagnosis and treatment have shifted from disease-focused therapy to full-lifecycle management. Therefore, digital healthcare solutions based on whole-course disease management have become a key area of exploration for the industry. BOTONG HEALTH’s comprehensive end-to-end digital healthcare solution aligns precisely with national and market demands for intelligent and smart healthcare services. Regarding the current state of digital healthcare development, she stated,“Digital therapeutics are not facing their twilight, but undergoing a rebirth.”, amidst the survival of the fittest,Value tools that withstand market scrutiny will always endure.

Ms. Ye Lei also introduced that the BTX Shutong Multidimensional Soothing Device is about to be launched. It combines TENS physical therapy with MBCT psychological therapy, offering a comprehensive pain management solution. With advantages of being non-addictive and non-invasive, it ensures high safety and can be used alone or in combination with medications and medical devices. Furthermore, it comprehensively records pain trajectories, tracks pain conditions and post-treatment changes, thereby facilitating better assessment of disease status and therapeutic efficacy.

BOTONG HEALTH's BTX Shutong Multi-Dimensional Soothing Device

BOTONG HEALTH’s holistic pain solution, empowered by digital health, covers the entire process of diagnosis, treatment, and prognosis throughout the course of disease. Currently, BOTONG HEALTH’s holistic pain solution has formed a “pyramid” structure.

The Pyramid Structure of BOTONG HEALTH’s Comprehensive Solutions

The base of the “Pyramid” is a digital healthcare product matrix centered on the BTS Multidimensional Pain Assessment and Support System. It encompasses hardware and software solutions for pain diagnosis and treatment, enabling the continuation of out-of-hospital home-based pain therapy and management, facilitating multidisciplinary precision diagnosis, assisting in etiological determination, and providing precise and comprehensive assessment of pain conditions.

The “Pyramid” structure refers to the “CPDP Project for Standardizing Cancer Pain Management Capacity within Medical Consortia.” Supported by the China Medical and Health Development Foundation, experts from the National Health Commission’s Pain Quality Control Center, the Supportive Care and Rehabilitation Committee (SCRC) of the Chinese Society of Clinical Oncology, and the Cancer Rehabilitation and Palliative Care Committee (CRPC) of the China Anti-Cancer Association, this project aims to establish a comprehensive system for cancer pain treatment and management, encompassing institutional frameworks, quality control, standards, training, and assessment. It seeks to empower healthcare institutions at all levels to implement new concepts, technologies, and models in offline practice.

At the apex of the “pyramid” is the Pain ICU (PAINICU) ward, where analgesic sign detection devices and pain assessment robots collect patients’ vital sign parameters. After data analysis by the Pain Management System (PMS) and the Pain Imaging and Control Ultrasound System (PICUS), standardized treatment plans are generated to safely and effectively address critical challenges such as pain crises and refractory cancer pain.

In addition to the exploration of technologies and application scenarios,BOTONG HEALTH has also established an innovative business and management model—the Dumbbell Model.: One end comprises the medical services segment; the other end focuses on training and clinical research for physicians. These two ends are connected by a data interaction management platform, where data from both sides is aggregated. The platform then leverages this data to enrich and upgrade its products, feeding the enhanced offerings back into both business segments.

BOTONG HEALTH's Dumbbell Model

On the healthcare service side,BOTONG HEALTH first utilizes its digital health platform product, BTS, to conduct patient assessments. Based on the assessment results, patients are advised to visit offline medical service points for corresponding treatment. After treatment is completed, long-term management is carried out through the digital health product, BTX.In the training and research sector,BOTONG HEALTH is committed to building the Comprehensive Pain Management Monitoring Network (CPain), collaborating with medical institutions to provide physicians with training and education, pain quality control, and real-world research services.

In terms of products, BOTONG HEALTH has established a closed-loop service system spanning assessment, diagnosis and treatment, and management. Its end-to-end pain management platform integrates the BTS (6D Multidimensional Pain Assessment System), BTC (Multidisciplinary Cancer Pain Consultation System), and BTX (Shutong Multidimensional Relief Device). Based on this framework, BOTONG HEALTH has also developed standardized clinical pathways for pain treatment.Developed a Pain Management System (PMS) and an In-Hospital Pain Monitoring System (PICUS); additionally, the CPM Cancer Pain Foundation Model is currently under training.To help medical institutions at all levels better implement standardized patient pain management.